FindTrial
Sign In

The significance of DNA Content in Cervical pre-Cancer Testing

The role of DNA Ploidy in Liquid Based Cytology for Cervical Pre- cancer and Cancer testing using Flow Cytometry - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061212
Enrollment
200
Registered
2024-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

Dr D Y Patil Vidyapeeth
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group 18-50years visiting gynecology OPD at Dr. D. Y. Patil Medical College, Hospital and research Centre for complaints of abnormal discharge will be screened

Exclusion criteria

Exclusion criteria: Pregnant women

Design outcomes

Primary

MeasureTime frame
The potential of Flow cytometry in cervical cancer diagnosis will be assessed. More easy and cost effective method would be available for screening program. Highly technical expertise needed for the cytological screening will be reduced with the flow cytometry.Timepoint: One time point at enrollment as this is an observational study—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Srikanth Tripathy

Dr D Y Patil Medical College Hospital and Research Centre Dr D Y Patil Vidyapeeth Pimpri

director.medicalresearch@dpu.edu.in02067115136

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026